Privia Health Group, Inc. (PRVA) Dividend History

Company News

• Privia Health Reports First Quarter 2025 Financial Results

  Privia Health Group, Inc. reported strong financial results for the first quarter of 2025, with increases in revenue, gross profit, operating income, and net income. The company also announced its expansion into the state of Arizona through a partnership with Integrated Medical Services, one of the largest independent multi-specialty practices in the state.

  GlobeNewswire Inc.
• Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27

  Privia Health Group, Inc. (Nasdaq: PRVA) announced that it will release its fourth quarter and full-year 2024 financial results on February 27, 2025, and host a conference call to discuss the results.

  GlobeNewswire Inc.
• U.S. Primary Care Physicians Market Report 2024-2028: Trends and Challenges Shaping the Market, with Insights by Age Group, Type of Physician and Service

  The U.S. primary care physicians market is expected to grow by $46.15 billion from 2022-2027, driven by demographic shifts, healthcare access, and the increasing prevalence of chronic diseases. Key trends include telehealth integration, patient-centered medical homes, and digital health adoption.

  GlobeNewswire Inc.

  Featured Companies: AMZN APO UNH
• Privia Health to Participate in the William Blair Growth Stock Conference

  Privia Health to Participate in the William Blair Growth Stock Conference

  GlobeNewswire Inc.
• What 12 Analyst Ratings Have To Say About Privia Health Gr

  Ratings for Privia Health Gr (NASDAQ:PRVA) were provided by 12 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 7 3 2 0 0 Last 30D 1 0 0 0 0 1M Ago 3 0 0 0 0 2M Ago 1 0 0 0 0 3M Ago 2 3 2 0 0 Analysts have set 12-month price targets for Privia Health Gr, revealing an average target of $26.42, a high estimate of $37.00, and a low estimate of $21.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 16.92%. Decoding Analyst Ratings: A Detailed Look The standing of Privia Health Gr among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Jailendra Singh Truist Securities Lowers Buy $24.00 $28.00 Richard Close Canaccord Genuity Lowers Buy $26.00 $37.00 Craig Jones Stifel Lowers Buy $24.00 $28.00 Daniel Grosslight Citigroup Announces Buy $25.00 - Richard Close Canaccord Genuity Lowers Buy $37.00 $41.00 Lisa Gill JP Morgan Lowers Overweight $30.00 $38.00 Andrew Mok Barclays Announces Equal-Weight $22.00 - Andrew Mok UBS Lowers Buy $29.00 $31.00 Gary Taylor TD Cowen Lowers Outperform $26.00 $30.00 Jailendra Singh Truist Securities Lowers Buy $28.00 $32.00 Elizabeth Anderson Evercore ISI Group Lowers Outperform $25.00 $26.00 Adam Ron B of A Securities Lowers Neutral $21.00 $27.00 Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions ...Full story available on Benzinga.com

  Benzinga